AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2020
Mar 6, 2020
33251_dirs_2020-03-06_a097e6f7-60c0-4274-9f78-10d42fc5a2d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2020-03-04
Reporting Person: Petersen Deanna M (Chief Business Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 151342 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.20 | 2026-10-24 | Common Stock (27658) | Direct | |
| Stock Option (Right to Buy) | $.91 | 2027-06-12 | Common Stock (60654) | Direct | |
| Stock Option (Right to Buy) | $5.00 | 2028-03-15 | Common Stock (46638) | Direct | |
| Stock Option (Right to Buy) | $16.98 | 2029-02-24 | Common Stock (78000) | Direct |
Footnotes
F1: 25% of the shares vested on October 25, 2017, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F2: 25% of the shares vested on June 13, 2018, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F3: 25% of the shares vested on March 16, 2019, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F4: 25% of the shares vested on February 25, 2020, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.